Case Comprehensive Cancer Center: Endometrial Neoplasms trials

The registry lists 12 Endometrial Neoplasms studies with Case Comprehensive Cancer Center as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 1 2Phase 2 2Phase 3 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing SurgeryTerminatedNCT01939028Not applicableResults posted
• Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological MalignanciesCompletedNCT01079832Phase 2Results posted
• Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for CancerCompletedNCT00245050Phase 3Results posted
• Pembrolizumab With Axitinib in Recurrent Endometrial CancerWithdrawnNCT04197219Phase 2
• Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical HyperplasiaCompletedNCT02342730Not applicable
• Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer SurvivorsCompletedNCT02135562Not applicable
• Assisted Exercise in Obese Endometrial Cancer PatientsCompletedNCT01870947Not applicable
• Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological CancerCompletedNCT01652794Phase 1
• Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial CancerCompletedNCT00735514
• Exercise and Healthy Diet or Standard Care in Patients in Remission From Stage I or Stage II Endometrial CancerCompletedNCT00732173Not applicable
• Lifestyle Change and Quality of Life in Obese Patients With Stage I/II Endometrial Cancer in RemissionCompletedNCT00262938Not applicable
• Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic CancerWithdrawnNCT00118300Phase 1